AbCellera Biologics Inc. (ABCL) Social Stream
ABCELLERA BIOLOGICS INC (ABCL) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering ABCL.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 5 | $53 | $25 | $42.75 | $5.71 | 648.69% |
| 2021-12-05 | 5 | $53 | $25 | $40.8 | $5.71 | 614.54% |
| 2021-12-19 | 7 | $53 | $25 | $39.833 | $5.71 | 597.6% |
| 2021-12-21 | 7 | $53 | $25 | $38 | $5.71 | 565.5% |
| 2022-02-11 | 5 | $45 | $25 | $33 | $5.71 | 477.93% |
| 2022-02-25 | 5 | $40 | $20 | $30 | $5.71 | 425.39% |
| 2022-05-09 | 5 | $40 | $20 | $29.6 | $5.71 | 418.39% |
| 2022-05-11 | 5 | $32 | $14 | $24.8 | $5.71 | 334.33% |
| 2022-08-09 | 5 | $32 | $14 | $23.6 | $5.71 | 313.31% |
| 2022-08-11 | 5 | $34 | $14 | $24 | $5.71 | 320.32% |
| 2022-10-23 | 5 | $34 | $13 | $23.8 | $5.71 | 316.81% |
| 2022-11-02 | 4 | $34 | $13 | $23.6 | $5.71 | 313.31% |
| 2022-11-09 | 5 | $32 | $20 | $23.6 | $5.71 | 313.31% |
| 2022-11-30 | 6 | $32 | $20 | $24.5 | $5.71 | 329.07% |
| 2022-12-15 | 6 | $32 | $20 | $25.285 | $5.71 | 342.82% |
| 2023-01-06 | 6 | $32 | $18 | $25 | $5.71 | 337.83% |
| 2023-02-21 | 7 | $32 | $18 | $25 | $5.71 | 337.83% |
| 2023-02-22 | 7 | $32 | $18 | $26.142 | $5.71 | 357.83% |
| 2023-04-20 | 7 | $32 | $16 | $26.833 | $5.71 | 369.93% |
| 2023-05-04 | 7 | $32 | $15 | $25.833 | $5.71 | 352.42% |
| 2023-05-11 | 7 | $32 | $15 | $25.666 | $5.71 | 349.49% |
| 2023-05-26 | 7 | $31 | $15 | $25 | $5.71 | 337.83% |
| 2023-08-03 | 7 | $32.001 | $15 | $26.166 | $5.71 | 358.25% |
| 2023-08-07 | 7 | $32.001 | $13 | $25.833 | $5.71 | 352.42% |
| 2023-08-31 | 8 | $32 | $12 | $23 | $5.71 | 302.8% |
| 2023-11-02 | 9 | $32 | $12 | $22.625 | $5.71 | 296.23% |
| 2023-11-03 | 10 | $32 | $10 | $20.75 | $5.71 | 263.4% |
| 2023-12-05 | 10 | $32 | $6 | $19.111 | $5.71 | 234.69% |
The Trend in the Analyst Price Target
Over the past 41 weeks, ABCL's average price target has gone down $5.89.
Over the past 41 weeks, ABCL's average upside potential has been 288.48%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-22 | 7 | 32.000 | 18 | 26.142 | 8.79 | 197.41% |
| 2023-07-21 | 7 | 32.001 | 15 | 26.166 | 7.85 | 233.32% |
| 2023-08-07 | 7 | 32.001 | 13 | 24.833 | 5.85 | 324.5% |
| 2023-11-02 | 9 | 32.000 | 12 | 22.625 | 4.43 | 410.72% |
| 2023-11-03 | 9 | 32.000 | 10 | 20.750 | 4.70 | 341.49% |
ABCL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.2 | 9 | 0 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
ABCL's average broker recommendation rating worsened by 0.2 over the prior 31 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, ABCELLERA BIOLOGICS INC's upside potential (average analyst target price relative to current price) is higher than 3967.76% of them.
- ABCELLERA BIOLOGICS INC's number of analysts covering the stock is higher than 396.03% of stocks in the large market cap category.
- In terms of how ABCELLERA BIOLOGICS INC fares relative to stocks in the large market cap category, note that its average analyst price target is greater than 679.28% of that group.
- In terms of how ABCELLERA BIOLOGICS INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -3160.83% of that group.
In the Pharmaceutical Products industry, BLUE, NTLA, and APLS are the three stocks most similar to ABCELLERA BIOLOGICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is ABCL a Buy, Hold or Sell? See the POWR Ratings now!